Clinical Trial Update: Response of Hepatic Tumors to Radioembolization [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic tumors (hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and liver metastases) after radioembolization has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Intrahepatic Cholangiocarcinoma
• Liver Metastases

Snippet

Sponsor: University of Zurich | Conditions: Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma | Phase 2 | Status: WITHDRAWN